Florian Hucke
Klinikum Klagenfurt(AT)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Hepatitis C virus research, Hepatitis B Virus Studies
Most-Cited Works
- → NASH limits anti-tumour surveillance in immunotherapy-treated HCC(2021)1,187 cited
- → The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma(2013)341 cited
- → Transarterial chemoembolization: Modalities, indication, and patient selection(2015)331 cited
- → Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score(2021)286 cited
- → Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib(2012)194 cited
- → How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma(2014)158 cited
- → Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma(2012)135 cited
- → Programmed cell death protein‐1 (PD‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world cohort(2019)130 cited
- → Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response‐Based Approach(2019)128 cited
- → The ART-strategy: Sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE(2013)117 cited